UBU7:F:F-UBS (Irl) ETF Public Limited Company - MSCI World UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 85.814

Change

+0.73 (+0.86)%

Market Cap

USD 0.66B

Volume

476.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.14 (-0.27%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-3.92 (-0.70%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.70 (-0.30%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.74 (-0.74%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+0.35 (+0.16%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.74 (-0.58%)

USD 24.77B

ETFs Containing UBU7:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.39% 33% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.39% 33% F 45% F
Trailing 12 Months  
Capital Gain 7.69% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.69% 66% D+ 57% F
Trailing 5 Years  
Capital Gain 74.94% 74% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.94% 74% C 54% F
Average Annual (5 Year Horizon)  
Capital Gain 14.73% 87% B+ 75% C
Dividend Return 14.73% 84% B 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.18% 20% F 68% D+
Risk Adjusted Return 73.02% 74% C 80% B-
Market Capitalization 0.66B 65% D 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.